Company intelligence / Profile preview
Avid Radiopharmaceuticals
Philadelphia, Pennsylvania, United Statesen.wikipedia.org ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
Avid developed Amyvid® (florbetapir F 18), the first FDA-approved PET imaging agent to detect beta amyloid plaques in living patients, enabling earlier and more accurate diagnosis of Alzheimer’s disease. Its second major product, Tauvid® (flortaucipir F 18), is also FDA-approved for imaging tau pathology. The company has additional agents in clinical development targeting neurodegenerative diseases and diabetes. Clinical results have shown these tracers can reliably identify hallmark pathologies of Alzheimer's and related conditions, supporting their use in both research and clinical practice[1][3][8].
- Therapeutic areas
- EndocrinologyPsychiatryNeurology
- Modalities
- Diagnostic radiopharmaceuticalsSmall molecules[6][10]
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
– University of Pennsylvania for technology licensing[1]– Academic collaborations including Johns Hopkins Hospital, Skåne University Hospital, ADNI initiative support [1][9][10]
Beyond the preview
Go deeper on Avid Radiopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avid Radiopharmaceuticals.